Man battling aggressive cancer gets final wish of one last motorcycle ride

KANSAS CITY, Mo. - At 57 years old, Craig Brunner says many of his favorite memories took place on his bike."I just miss being on the motorcycle, miss our trips, miss that open air," his wife, Diane Brunner, told WDAF.After being diagnosed with an aggressive cancer, he was forced to stay off his motorcycle.

DNA-matched cancer treatment could increase survival rates as much as 6-fold

HOUSTON, Texas -- A new way of treating cancer that involves individual DNA sequencing could change survival rates, according to a new study.Researchers at the University of Texas' MD Anderson Cancer Center said they think individually matching your cancer treatment to a DNA sequencing, rather than the location of the cancer, could not only change the treatment type chosen, but it could also lead to a survival rate of that increases as much as six-fold.The study was presented at the American Society of Clinical Oncology.The results are being hailed as the biggest cancer breakthrough since chemotherapy.New treatments involve the individual analysis of DNA from a tumor that would let doctors individualize the particular cancer treatment because of the cancer's DNA, rather than commonly relying on the treatment based on the site location of the cancer, such as breast cancer, prostate cancer or lung cancer.One University of Texas researcher, Apostolia Maria Tsimberidou, said this "next-generation" sequencing should become a common method to fight cancer.CLICK HERE to view this study.

Many breast cancer patients can skip chemo, big study finds

CHICAGO — Most women with the most common form of early-stage breast cancer can safely skip chemotherapy without hurting their chances of beating the disease, doctors are reporting from a landmark study that used genetic testing to gauge each patient's risk.The study is the largest ever done of breast cancer treatment, and the results are expected to spare up to 70,000 patients a year in the United States and many more elsewhere the ordeal and expense of these drugs."The impact is tremendous," said the study leader, Dr.

Shorter drug treatment OK for many breast cancer patients

Many women with a common and aggressive form of breast cancer that is treated with Herceptin can get by with six months of the drug instead of the usual 12, greatly reducing the risk of heart damage it sometimes can cause, a study suggests.It's good news, but it comes nearly two decades after the drug first went on the market and many patients have suffered that side effect.The study was done in the United Kingdom and funded by UK government grants.

Teen initially told he might have the flu finds out he has Stage 4 cancer

TAMPA, Fla. – Doctors told 16-year-old Hunter Brady in November that his shortness of breath and exhaustion were probably signs of the flu, according to WFTS.It wasn't until a Brady's right lung collapsed a few weeks later and he was rushed to the emergency room that he found out he had cancer."I just kept sweating a lot, like night sweats," Brady said. "As it carried on I felt worse."In January, tests revealed that Brady had Stage 4 Hodgkin's Lymphoma, his mother told the Florida station.The 16-year-old has already undergone a blood transfusion, bone marrow biopsy and several operations to remove fluid building up around his lungs and heart.

What is Buddy Check 6?

MILWAUKEE -- The earlier you catch cancer, the better your chances of beating it!

With help from friends, 20-year-old man with cancer lives out bucket list

CITRUS HEIGHTS, Calif. – If you spend some time with Chris Betancourt, the first thing you'll notice is that he acts like a completely normal 20-year-old man."I put two legs in one pant leg this morning, I don't think I'm an inspiration," he told KTXL. "But it's amazing to see people think I'm an inspiration."But Chris and his friends, who all call themselves ordinary, are doing some extraordinary things.

US OKs 1st drug aimed at women with inherited breast cancer

U.S. regulators have approved the first drug aimed at women with advanced breast cancers caused by an inherited flawed gene.The Food and Drug Administration on Friday approved AstraZeneca PLC's Lynparza for patients with inherited BRCA gene mutations who have undergone chemotherapy.It's the first in a fairly new class of medicines for ovarian cancer called PARP inhibitors to also win approval for treating breast cancer.PARP inhibitors prevent cancer cells from fixing problems in their DNA.